Skip to main content
Brian Vickery, MD, Allergy & Immunology, Atlanta, GA

BrianP.VickeryMD

Allergy & Immunology Atlanta, GA

Pediatric Asthma & Allergic Conditions

Assistant Professor of Pediatrics, University of North Carolina School of Medicine

Dr. Vickery is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vickery's full profile

Already have an account?

  • Office

    1400 Tullie Rd NE
    Atlanta, GA 30329
    Phone+1 404-785-5437
    Fax+1 404-785-9111

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Allergy and Immunology, 2005 - 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2001 - 2004
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2001
  • University of Georgia
    University of GeorgiaB.S., Cellular Biology, Cum Laude, 1997

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2017 - 2025
  • NC State Medical License
    NC State Medical License 2008 - 2018
  • NY State Medical License
    NY State Medical License 2003 - 2006
  • CT State Medical License
    CT State Medical License 2005 - 2005
  • American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

  • Young Faculty Support Award Foundation of the American College of Allergy, Asthma, and Immunology, 2011
  • Barry Kay Award for Outstanding Pediatric Research British Society of Allergy & Clinical Immunology, 2011
  • Duke Medicine Service Champion Duke Medicine Patient and Visitor Relations, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Variants at the 16p13 Locus Confer Risk for Eosinophilic Esophagitis  
    Robert P Kimberly, Marc E Rothenberg, Patrick M Gaffney, Hugh A Sampson, J Pablo Abonia, Mirna Chehade, Philip E Putnam, Brian P Vickery, Glenn T Furuta, John B Harley, Nature
  • Peanut Oral Immunotherapy Modifies IgE and IgG(4) Responses To Major Peanut Allergens  
    Vickery BP, Lin J, Kulis M, Fu Z, Steele P, Jones SM, Scurlock AM, Gimenez G, Bardina L, Sampson HA, Burks AW, J Allergy Clin Immunol, 1/1/2013
  • Synopsis Book: Best Articles Relevant to Pediatric Allergy and Immunology  
    Pediatrics, 10/1/2012
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Early Intervention is a Promising Strategy for the Treatment of Peanut Allergy
    Vickery BP, AAAAI Annual Meeting Poster Session, Orlando, FL, 1/1/2012
  • The Antibody Response to Peanut Oral Immunotherapy (OIT) is Dynamic and Individualized
    Vickery BP, British Society of Allergy and Clinical Immunology Annual Meeting, Nottingham UK, 1/1/2011
  • Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy
    Vickery BP, AAAAI Annual Meeting Poster Session, San Francisco, CA, 1/1/2011
  • Join now to see all

Lectures

  • Food Allergy: A Literature Review 
    Greensboro, NC - 7/1/2014
  • Food Allergy Research: 2014 Update 
    Chicago, IL - 6/1/2014
  • Food Allergies and Testing - What Pediatricians Need to Know 
    UNC-Chapel Hill - 4/1/2014
  • Join now to see all

Other

  • Advances in Food Allergy 2011 
    Vickery BP, AAAAI/New Allergists/Immunologists Assembly and Journal of Allergy and Clinical Immunology Webinar
    12/1/2011

Press Mentions

  • CHOA Study Shows Promise in Treating Kids' Peanut Allergies. A New Clinical Trial Opens This Summer
    CHOA Study Shows Promise in Treating Kids' Peanut Allergies. A New Clinical Trial Opens This SummerMay 22nd, 2023
  • Child Peanut Allergy Patch Completes Phase 3 Trial, Awaits FDA Approval
    Child Peanut Allergy Patch Completes Phase 3 Trial, Awaits FDA ApprovalMay 18th, 2023
  • Children’s Participates in Immunotherapy Trial for Children with Peanut Allergy
    Children’s Participates in Immunotherapy Trial for Children with Peanut AllergyMay 16th, 2023
  • Join now to see all

Professional Memberships